Open access
Open access
Powered by Google Translator Translator

M-A | Risk of cardiovascular diseases associated with medications used in ADHD.

25 Nov, 2022 | 12:16h | UTC

Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis – JAMA Network Open

Commentaries: 

Paying Attention to Attention-Deficit/Hyperactivity Disorder Medications and Cardiovascular Risk – JAMA Network Open

Meta-Analysis Finds ADHD Drugs Not Linked To Risk Of Cardiovascular Disease – Reporter Health

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.